XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome

Nature

Volumn 444, Issue 7115, 2006, Pages 110-114

  Rigaud, Stéphanie ^a   Fondanèche, Marie Claude ^a   Lambert, Nathalie ^a,b   Pasquier, Benoit ^a   Mateo, Véronique ^a   Soulas, Pauline ^a   Galicier, Lionel ^c   Le Deist, Françoise ^a,b   Rieux Laucat, Frédéric ^a   Revy, Patrick ^a   Fischer, Alain ^a,b   De Saint Basile, Geneviève ^a   Latour, Sylvain ^a  

^a INSERM   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELLS; MOLECULES; MUTAGENS;

EPSTEIN-BARR VIRUS (EBV); IMMUNE HOMEOSTASIS; SIGNALLING LYMPHOCYTE ACTIVATION MOLECULE (SLAM); X-LINKED LYMPHOPROLIFERATIVE SYNDROME (XLP);

VIRUSES;

CD3 ANTIGEN; DEATH RECEPTOR; FAS ANTIGEN; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; T LYMPHOCYTE RECEPTOR; X LINKED INHIBITOR OF APOPTOSIS;

ANTIGEN; APOPTOSIS; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNE SYSTEM; MUTATION; VIRUS;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; X CHROMOSOME LINKED DISORDER;

HUMAN HERPESVIRUS 4;

EID: 33750597717     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05257     Document Type: Article

References (21)

1. de Saint Basile, G. & Fischer, A. Defective cytotoxic granule-mediated cell death pathway impairs T lymphocyte homeostasis. Curr. Opin. Rheumatol. 15, 436-445 (2003).
2. Rathmell, J. C. & Thompson, C. B. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109 (Suppl.), S97-107 (2002).
3. Purtilo, D. T., Cassel, C. K., Yang, J. P. & Harper, R. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1, 935-940 (1975).
4. Nichols, K. E., Ma, C. S., Cannons, J. L., Schwartzberg, P. L. & Tangye, S. G. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol. Rev. 203, 180-199 (2005).
5. Gaspar, H. B., Sharifi, R., Gilmour, K. C. & Thrasher, A. J. X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective. Br. J. Haematol. 119, 585-595 (2002).
6. Nichols, K. E. et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl Acad. Sci. USA 95, 13765-13770 (1998).
7. Sayos, J. et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395, 462-469 (1998).
8. Coffey, A. J. et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nature Genet. 20, 129-135 (1998).
9. Nichols, K. E. et al. Regulation of NKT cell development by SAP, the protein defective in XLP. Nature Med. 11, 340-345 (2005).
10. Pasquier, B. et al. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201, 695-701 (2005).
11. Salvesen, G. S. & Duckett, C. S. IAP proteins: blocking the road to death's door. Nature Rev. Mol. Cell Biol. 3, 401-410 (2002).
12. Vaux, D. L. & Silke, J. IAPs, RINGs and ubiquitylation. Nature Rev. Mol. Cell Biol. 6, 287-297 (2005).
13. Parolini, S. et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192, 337-346 (2000).
14. Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. & Wakao, H. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21, 483-513 (2003).
15. Rieux-Laucat, F., Fischer, A. & Deist, F. L. Cell-death signaling and human disease. Curr. Opin. Immunol. 15, 325-331 (2003).
16. Lenardo, M. et al. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17, 221-253 (1999).
17. Harlin, H., Reffey, S. B., Duckett, C. S., Lindsten, T. & Thompson, C. B. Characterization of XIAP-deficient mice. Mol. Cell. Biol. 21, 3604-3608 (2001).
18. + T cells for accelerated suicide causes immune incompetence. J. Clin. Invest. 111, 1191-1199 (2003).
19. Schimmer, A. D., Dalili, S., Batey, R. A. & Riedl, S. J. Targeting XIAP for the treatment of malignancy. Cell Death Differ. 13, 179-188 (2006).
20. Strauss, G., Knape, I., Melzner, I. & Debatin, K. M. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells. J. Immunol. 171, 1172-1182 (2003).
21. Zennou, V. et al. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101, 173-185 (2000).